Laurus Labs Limited

NSE: LAURUSLABSHealthcareLot size: 850

Laurus Labs Limited FII & DII Activity

FII Net (₹ Cr)
+871.83Buy 16,834.53Sell 15,962.7
DII Net (₹ Cr)
+643.35Buy 17,240.9Sell 16,597.55
FII F&O Net (contracts)
+643395Index + stock futures

5-Day Flow Trend

DateFII Net (₹ Cr)DII Net (₹ Cr)
2026-10-28+871.83+643.35
2026-10-27−1462.49+2609.57
2026-10-26−1462.49+2609.57
2026-10-23+887.65+3235.36
2026-10-22−3458.70+2891.32
AI AnalysisGenerated daily after market close · AI-powered

Today's Institutional Flow

On October 28, 2026, foreign institutional investors (FII) recorded a net cash inflow of ₹871.83 crore, while domestic institutional investors (DII) added a net cash inflow of ₹643.35 crore to the market in equities during the session. Both categories contributed positively to overall market liquidity, indicating a broadly supportive trading environment despite broader macro‑economic uncertainties that have been prevalent in recent weeks for equities. The simultaneous rise in foreign and domestic cash participation suggests that investors are reinforcing bullish sentiment rather than reallocating capital across asset classes in the Indian market.

Trend vs 5-Day Average

Today's FII cash inflow contrasts sharply with its five‑day average of a ₹894.74 crore outflow, marking a reversal of recent net selling pressure this week. Conversely, DII cash activity remains modest relative to its five‑day average of a ₹2,592.03 crore inflow, indicating that domestic investors are still accumulating at a slower pace currently.

F&O Positioning Data

FII futures and options (F&O) positions show a net long of approximately ₹643,395 crore, reflecting substantial speculative exposure in the derivatives market across multiple contracts. The index futures long‑short ratio stands at 1.2, implying that for every short contract there are roughly 1.2 long contracts, a mild bullish tilt in the near term.

Healthcare Sector Flow

Within the healthcare sector, recent weeks have seen FII turning net buyers while DII continues modest inflows, underscoring a generally supportive stance toward pharma equities as of the data.

Market-wide FII/DII data — same for all F&O stocks. Date: 2026-10-28

Frequently Asked Questions

What is FII net buying/selling in Laurus Labs Limited today?
FII (Foreign Institutional Investor) net flow in the Indian cash market today is ₹871.83 Cr (net buying) as of 2026-10-28. This market-wide figure applies to all F&O stocks including Laurus Labs Limited.
What is DII activity in Laurus Labs Limited today?
DII (Domestic Institutional Investors — mutual funds, insurance companies) net flow is ₹643.35 Cr (net buying) today. DIIs often act as a counterbalancing force to FII flows — on days when FIIs sell, DIIs typically provide support.
What is FII F&O net for Laurus Labs Limited today?
FII net F&O position (index + stock futures combined) is +6,43,395 contracts as of the latest participant OI data. A positive number means FIIs are net long in futures; negative means net short.
Were there any block deals in Laurus Labs Limited?
Block deal data for Laurus Labs Limited is tracked daily from NSE's block deal window. On days with activity, the deal value in ₹ Crore is shown on this page.
How does FII/DII data affect Laurus Labs Limited stock price?
FII and DII flows are market-wide data — all F&O stocks including Laurus Labs Limited are influenced. When FIIs buy heavily (positive net), it typically supports the broader market. When FII F&O net is strongly positive (long futures), it signals institutional conviction in an uptrend. Combined with Laurus Labs Limited's individual OI buildup type, this provides a directional framework.